#VELA Vela Technologies plc – Investee Company #ENSI EnSilica plc – Final Results October 17, 2022 – Posted in: Vela Technologies Plc (VELA)

EnSilica (AIM: ENSI), a leading mixed signal chipmaker announces full year results for the year ended 31 May 2022 (“FY 22”). Financial highlights · Revenue up 77% to £15.3 million (FY21: £8.6 million) · Adjusted operating profit £0.70 million (FY21 £0.17 million loss). · Gross margin 33% (FY21: 23.9%) · Adjusted EBITDA up significantly to £1.05 million (FY21: £0.06 million) · Cash and cash equivalents at 31 May 2022 of £5.7 million (31 May 2021: £1.4 million) · Net…

#POLB Poolbeg Pharma PLC – CEO Share Purchase October 6, 2022 – Posted in: Blog, Poolbeg Pharma (POLB)

6 October 2022 – Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, ‘Poolbeg’ or the ‘Company’), a clinical stage infectious disease pharmaceutical company with a unique capital light clinical model, has been notified that Chief Executive Officer, Jeremy Skillington, has purchased 718,733 ordinary shares of 0.02 pence each in the Company (“Ordinary Shares”) at a share price of 4.78 pence per share. Following the purchase, Jeremy Skillington’s beneficial interest in the Company is 718,733 Ordinary Shares, representing…

#VELA Vela Technologies plc – Investee Company #ENSI EnSilica plc – Final Results October 17, 2022 – Posted in: Vela Technologies Plc (VELA)

#POLB Poolbeg Pharma PLC – CEO Share Purchase October 6, 2022 – Posted in: Blog, Poolbeg Pharma (POLB)

Address

Contact

Social

LEGAL